Director Since: 2015
Michael S. Wyzga is an independent healthcare consultant. He served as President, Chief Executive Officer, and board member at Radius Health, Inc., a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health conditions from December 2011 to November 2013. Previously, Mr. Wyzga served in various senior management positions at Genzyme Corporation, a global biotechnology company. Mr. Wyzga joined Genzyme in March 1997 and most recently served as Executive Vice President, Finance from May 2003 until November 2011 and as Chief Financial Officer from July 1999 until November 2011. Mr. Wyzga currently serves as Chairman of the Board of Directors of Gensight Biologics S.A., a clinical-stage biologics company, Chairman of the Board of Directors of X4 Pharmaceuticals, a biopharmaceutical company, a director of Mereo BioPharma Group plc, a clinical-stage biopharmaceutical company, and LogiBio Therapeutics, Inc., a biopharmaceutical company. He previously served as a director of Akebia Therapeutics, Inc., Prosensa Holding N.V., and Idenix Pharmaceuticals, Inc. Mr. Wyzga holds a bachelor's degree from Suffolk University and a Master of Business Administration from Providence College. Mr. Wyzga brings extensive financial and managerial experience in the biotechnology and biopharmaceutical industries to our Board of Directors with key insight into financial and strategic initiatives as well as extensive public company board service within our industry.